CLINICAL_TRIALS
trial_result
· 2018-06-06
Clinical Trial Update: Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy [Phase 2]
Summary
Phase 2 clinical trial evaluating apatinib for advanced ovarian cancer after failure of standard chemotherapy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Anhui Provincial Hospital | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN